Clik here to view.
武田薬品とニューヨーク科学アカデミーが2020年Innovators in Science Awardの受賞者を発表
ニューヨーク & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（以下、「武田薬品」）（TSE:4502/NYSE:TAK）とニューヨーク科学アカデミーは本日、今年で第3回年次Innovators in Science...
View ArticleClik here to view.
MetLife’s 360Health Wins Gold Stevie®
HONG KONG MetLife’s 360Health has outshined several insurers and non-insurers to win the Gold Stevie® Award for Innovation in Heath & Wellness at the seventh annual Asia-Pacific Stevie Awards....
View ArticleClik here to view.
Global Demand for Innovation Prevails Over Challenges of COVID-19: New Report...
LONDON & BOSTON & TOKYO The impact of COVID-19 has so far wiped $7.85bn off forecasts for biopharma sales in 2020, with the top 15 companies bearing 60% of that loss, according to the...
View ArticleClik here to view.
NICEがフラットアイアン・ヘルスと提携し、実臨床データに基づく研究方法の開発へ
英マンチェスター & ニューヨーク （ビジネスワイヤ） — 英国国立医療技術評価機構（NICE、 www.nice.org.uk）は対ガン剤の研究と技術開発を手掛ける企業であるフラットアイアン・ヘルス（ www.flatiron.com）と提携しています。この連携は、実臨床データを通して医療技術の臨床有用性と医療経済性を評価することを目標としています。...
View ArticleClik here to view.
JW Therapeutics Acquires Syracuse Biopharma and License to Eureka...
SHANGHAI & EMERYVILLE, Calif. JW Therapeutics, a clinical stage biopharmaceutical company focused on developing, manufacturing and commercializing cell therapies for patients in China, today...
View ArticleClik here to view.
BostonGene and NEC Collaborate to Analyze Cancer Patients in Clinical Trials
WALTHAM, Mass. & TOKYO BostonGene Corporation (BostonGene), a biomedical software company focused on defining optimal precision medicine-based therapies for cancer patients, and NEC Corporation...
View ArticleClik here to view.
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for...
TOKYO & BASKING RIDGE, N.J. & MUNICH & VILLEJUIF, France Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Gustave Roussy today announced a multi-year, multi-study research...
View ArticleClik here to view.
Terns Pharmaceuticals Announces Initiation of Patient Dosing in the LIFT...
FOSTER CITY, Calif. & SHANGHAI Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis...
View ArticleClik here to view.
拓臻生物宣布其非酒精性脂肪性肝炎（NASH）候选药物TERN-101的Ⅱa期临床试验(LIFT) 完成首位患者给药
美国加州福斯特城与中国上海 (美国商业资讯)–Terns Pharmaceuticals 拓臻生物—一家专注肝脏疾病和癌症创新疗法研发的国际生物制药公司，今天宣布在名为LIFT的TERN-101的Ⅱa期临床试验中完成首位患者给药。TERN-101是一种具有肝脏选择性的法尼醇X受体（FXR）激动剂，是公司开发的针对非酒精性脂肪性肝炎（NASH）适应症的主要候选药物之一。...
View ArticleClik here to view.
Terns Pharmaceuticals、NASH治療薬として開発中のTERN-101の第2a相臨床試験LIFTで患者への投与を開始したと発表
米カリフォルニア州フォスターシティ & 上海 （ビジネスワイヤ） — 非アルコール性脂肪肝炎（NASH）とがんの革新的治療薬の創薬と開発に傾注する世界的バイオ製薬会社のTerns Pharmaceuticals,...
View ArticleClik here to view.
Hansoh Pharma Announces Strategic Collaboration and Licensing Agreement for...
SHANGHAI Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”; 3692.HK), a leading biopharmaceutical company in China, today announced a strategic collaboration and licensing agreement for...
View ArticleClik here to view.
Noxopharm Reports Idronoxil Achieves Major Industry Goal of Converting ‘Cold’...
SYDNEY Noxopharm, a clinical-stage Australian oncology drug development company listed on the ASX (ASX:NOX), has claimed a breakthrough in the search for restoring immune function within “cold”...
View ArticleClik here to view.
CORRECTING and REPLACING Hansoh Pharma Announces Strategic Collaboration and...
SHANGHAI First paragraph, fourth sentence of the release should read: Hansoh will receive approximately $100 million in upfront payment and development and regulatory milestones, with additional...
View ArticleClik here to view.
Daiichi Sankyo and AstraZeneca Enter New Global Development and...
TOKYO, MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that it has entered into a global development and commercialization agreement with...
View ArticleClik here to view.
Clik here to view.
Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License...
FOSTER CITY, Calif. & SHANGHAI Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, and...
View ArticleClik here to view.
Terns PharmaceuticalsとHansoh Pharmaが大中華圏におけるTRN-000632に関する協業・ライセンス契約を発表
米カリフォルニア州フォスターシティ & 上海 （ビジネスワイヤ） — 肝疾患とがんの革新的治療薬の創薬と開発に傾注する世界的バイオ製薬会社のTerns Pharmaceuticals, Inc.（上海拓臻生物科技有限公司）と、アジアの大手バイオ製薬会社のHansoh Pharmaceutical Group Company Limited（翰森製薬集団有限公司、“Hansoh...
View ArticleClik here to view.
Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
View ArticleClik here to view.
Clik here to view.
Takeda Announces FY2020 Q1 Results; Confirms Management Guidance & Raises...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2020 (quarter ended June 30, 2020). Based...
View Article